Article 54QDJ WHO gives up on hydroxychloroquine for COVID-19, stops trials

WHO gives up on hydroxychloroquine for COVID-19, stops trials

by
Beth Mole
from Ars Technica - All content on (#54QDJ)
GettyImages-1214260476-800x533.jpg

Enlarge / Pills of Hydroxychloroquine sit on a tray at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. (credit: Getty | George Frey)

The World Health Organization on Wednesday announced that it is abandoning use of the anti-malaria drug hydroxychloroquine in the Solidarity trial-the organization's massive, global clinical trial of potential COVID-19 treatments.

The WHO cited early data from the trial and others showing that hydroxychloroquine does not lower the risk of death or provide any other clinical benefit in hospitalized patients.

Investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial," the WHO said in a statement. Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician."

Read 12 remaining paragraphs | Comments

index?i=SeBKVnu_R7k:UKjBYCpNS-0:V_sGLiPB index?i=SeBKVnu_R7k:UKjBYCpNS-0:F7zBnMyn index?d=qj6IDK7rITs index?d=yIl2AUoC8zA
External Content
Source RSS or Atom Feed
Feed Location http://feeds.arstechnica.com/arstechnica/index
Feed Title Ars Technica - All content
Feed Link https://arstechnica.com/
Reply 0 comments